Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCleantech Lithium Regulatory News (CTL)

Share Price Information for Cleantech Lithium (CTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.263%)
Open: 19.50
High: 19.50
Low: 19.50
Prev. Close: 19.50
CTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Options Award, Issue of Equity & TVR

10 Nov 2022 07:00

RNS Number : 9020F
CleanTech Lithium PLC
10 November 2022
 

10 November 2022

 

CleanTech Lithium PLC ("CleanTech Lithium" or the "Company")

 

Award of Share Options, Director / PDMR Shareholding, Issue of Equity and TVR

 

CleanTech Lithium PLC (AIM: CTL, Frankfurt: T2N), an exploration and development company, advancing the next generation of sustainable lithium projects in Chile, further to the RNS announcements of 17 and 20 October 2022, announces the award of share options to the Company's Non-Executive Directors and the issue of 200,000 ordinary shares of £0.01 each ("Ordinary Shares") to Beyond Lithium LLC ("Beyond Lithium") ("Beyond Shares").

Award of Share Options

On 20 October 2022 the Company announced that it intends to make a one-off award of non-performance related share options to its Non-Executive Chairman, Steve Kesler, and to its other independent Non-Executive Director, Jonathan Morley-Kirk (together the "Non-Executive Directors") in recognition of the significant workload of both Non-Executive Directors in carrying out their duties as independent directors since the IPO in March 2022.

The Company now confirms that on 9 November 2022 it has awarded a total of 459,000 options over Ordinary Shares (the "Options"): 255,000 to Steve Kesler and 204,000 to Jonathan Morley-Kirk. The Options will vest annually over a three-year period on a time (but not performance) basis with effect from the date of the IPO (17 March 2022) and vested options may be exercised over a five-year period at a price of 57p per Ordinary Share.

The Company is satisfied that the award of these Options will not impair the independence of the Non-Executive Directors. The Company will, however, seek to appoint an additional independent non-executive director that will bring diverse experience and new skills and experience to a well-functioning Board at an appropriate time over the coming year. 

Following the award of Options, there are currently 7,408,000 share options outstanding representing 9.35% of the Company's issued share capital as enlarged by the allotment of Beyond Shares.

The information contained in Appendix 1 below is disclosed in accordance with Article 19 of the Market Abuse Regulation.

Issue of Equity

Further to the announced of 17 October 2022, the Company has on 9 November 2022 issued and allotted 200,000 Ordinary Shares to Beyond Lithium at a price of 46.25p per share, which was the closing mid-market price on 8 November 2022.

Application has been made to London Stock Exchange for the Beyond Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective, and trading in Beyond Shares will commence on AIM, at 8.00 a.m. on 14 November 2022.

Total Voting Rights ("TVR")

Following the issue of the Beyond Shares, the Company's total issued share capital will consist of 79,233,242 Ordinary Shares with voting rights. The Company does not hold any Ordinary Shares in treasury.

Accordingly, as from Admission the figure of 79,233,242 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

It should be noted though that the above TVR figure does not include the 26,100,258 new Ordinary Shares to be issued pursuant to the fundraising ("Fundraising Shares"), details of which were announced on 21 October 2022. The issue of the Fundraising Shares is subject to Shareholder approval at the Company's upcoming General Meeting on 14 November 2022, and it is expected that the Fundraising Shares will be admitted to trading on 16 November 2022.

 

For further information visit www.ctlithium.com or contact the following:

 

 

CleanTech Lithium PLC

 

Aldo Boitano

Jersey office: +44 (0) 1534 668 321

Chile office: +562-32239222

Or via Celicourt

 

Beaumont Cornish Limited

(Nominated Adviser)

Roland Cornish

 

+44 (0) 207 628 3396

Fox-Davies Capital Limited

(Joint Broker)

Daniel Fox-Davies

 

+44 (0) 20 3884 8450

 

daniel@fox-davies.com

 

Canaccord Genuity Limited

(Joint Broker)

James Asensio

Gordon Hamilton

 

+44 (0) 207 523 4680

 

 

Celicourt Communications

Felicity Winkles/Philip Dennis

 

+44 (0) 20 8434 2754

ctl@celicourt.uk

Dr. Reuter Investor Relations

Dr. Eva Reuter

+49 69 1532 5857

 

 

Appendix 1

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

1

Details of the person discharging managerial responsibilities person closely associated

a)

Name

Steve Kesler

2

Reason for notification

a)

Position / status

Non-Executive Chairman

b)

Initial notification/Amendment

Initial

3

Details of the issueremission allowancmarkeparticipant, auction platform, auctioneer or auction monitor

a)

Name

CleanTech Lithium Plc

b)

LEI

213800Y3TN5JQCDA9U59

4

Details of thtransaction(s): section tbrepeatefor (ieactype of instrument(ii) eactype of transaction(iii) eacdate; an(iv) eacplacwhertransactionhave beeconducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares of GBP 0.01

ISIN: JE00BPCP3Z37

b)

Nature of the transaction

Award of options

c)

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

57 pence

255,000

d)

Aggregated information

Aggregate volume

Price(s)

 

N/A

 

e)

Date of the transaction

2022-11-09

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities person closely associated

a)

Name

Jonathan Morley-Kirk

2

Reason for notification

a)

Position / status

Non-Executive Director

b)

Initial notification/Amendment

Initial

3

Details of the issueremission allowancmarkeparticipant, auction platform, auctioneer or auction monitor

a)

Name

CleanTech Lithium Plc

b)

LEI

213800Y3TN5JQCDA9U59

4

Details of thtransaction(s): section tbrepeatefor (ieactype of instrument(ii) eactype of transaction(iii) eacdate; an(iv) eacplacwhertransactionhave beeconducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares of GBP 0.01

ISIN: JE00BPCP3Z37

b)

Nature of the transaction

Award of options

c)

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

57 pence

204,000

d)

Aggregated information

Aggregate volume

Price(s)

 

N/A

 

e)

Date of the transaction

2022-11-09

f)

Place of the transaction

Outside a trading venue

 

Notes

 

CleanTech Lithium (AIM:CTL) is an exploration and development company, advancing the next generation of sustainable lithium projects in Chile. The Company's mission is to produce material quantities of battery grade lithium from 2025 onwards, with near zero carbon emissions and low environmental impact, offering the EU EV market a green lithium supply solution.

 

CleanTech Lithium has two prospective lithium projects - Laguna Verde and Francisco Basin projects located in the lithium triangle, the world's centre for battery grade lithium production. They are situated within basins entirely controlled by the Company, which affords significant potential development and operational advantages. The projects have direct access to excellent infrastructure and renewable power. The Company has also further applied for an additional 119 exploration licences at Llamara, as a low cost and commitment greenfield project to complement the existing more advanced projects.

 

CleanTech Lithium is committed to using renewable power for processing and reducing the environmental impact of its lithium production by utilising Direct Lithium Extraction. Direct Lithium Extraction is a transformative technology which only removes lithium from brine, with higher recoveries and purities. The method offers short development lead times, low upfront capex, with no extensive site construction and no evaporation pond development so there is no water depletion from the aquifer or harm to the local environment.

 

**ENDS**

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSTLILAIIF
Date   Source Headline
31st Mar 202312:54 pmRNSGrant of Options, Exercise of Options and TVR
31st Mar 20239:05 amRNSSecond Price Monitoring Extn
31st Mar 20239:00 amRNSPrice Monitoring Extension
31st Mar 20237:00 amRNSOperations and Corporate Update
28th Mar 20237:00 amRNSBoard changes to advance next phase of development
24th Feb 20237:00 amRNSProposed Listing on Australian Securities Exchange
22nd Feb 202311:09 amRNSHolding(s) in Company
15th Feb 20237:00 amRNSCommencement of Trading on OTCQB Venture Market
10th Feb 20232:05 pmRNSSecond Price Monitoring Extn
10th Feb 20232:00 pmRNSPrice Monitoring Extension
8th Feb 20239:05 amRNSSecond Price Monitoring Extn
8th Feb 20239:00 amRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSLlamara - Licences Granted and Operational Plans
20th Jan 202310:16 amRNSPreliminary Events Schedule for H1 2023
6th Jan 20237:00 amRNSInvestor Webinar
5th Jan 20237:00 amRNSScoping Study - Laguna Verde Lithium Project
21st Dec 20227:00 amRNSNotice of Scoping Study and Corporate Film
15th Dec 20227:00 amRNSApplication to cross trade on the U.S. OTCQX
6th Dec 20227:00 amRNSOperations and Corporate Update
1st Dec 20222:08 pmRNSTotal Voting Rights
21st Nov 20224:04 pmRNSHolding(s) in Company
14th Nov 20221:14 pmRNSResult of General Meeting and Total Voting Rights
10th Nov 20227:00 amRNSOptions Award, Issue of Equity & TVR
7th Nov 20227:00 amRNSIR Programme: Germany, Switzerland, Australia
24th Oct 20226:00 pmRNSInvestor Webinar and New Corporate Website
24th Oct 20225:25 pmRNSNotice of General Meeting
21st Oct 20227:00 amRNSResults of Fundraising
20th Oct 20225:09 pmRNSPrimaryBid Offer
20th Oct 20224:40 pmRNSProposed Placing
17th Oct 20227:00 amRNSOperations an Corporate Upate
17th Oct 20227:00 amRNSOperations and Corporate Update
14th Oct 20224:42 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSDirect Lithium Extraction Process Work Commences
12th Oct 202211:05 amRNSSecond Price Monitoring Extn
12th Oct 202211:00 amRNSPrice Monitoring Extension
6th Oct 20221:30 pmRNSInvestor Webinar: Francisco Resource & Co. Update
6th Oct 202211:05 amRNSSecond Price Monitoring Extn
6th Oct 202211:00 amRNSPrice Monitoring Extension
3rd Oct 20227:00 amRNSFrancisco Basin: Maiden Resource, New Li Discovery
26th Sep 202211:05 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
16th Sep 20223:47 pmRNSGrant of Options & Director/PDMR Shareholdings
15th Sep 20227:00 amRNSInterim Results
13th Sep 202210:49 amRNSResource Upgrade
12th Sep 20227:00 amRNSHolding(s) in Company
9th Sep 20222:06 pmRNSSecond Price Monitoring Extn
9th Sep 20222:01 pmRNSPrice Monitoring Extension
9th Sep 202211:00 amRNSPrice Monitoring Extension
5th Sep 20224:41 pmRNSSecond Price Monitoring Extn
5th Sep 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.